Ireland - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, Ireland Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry jumped by 16.9% year on year. At $407,799,563.58 Million PPP in 2019, the country was number 18 comparing other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry. Ireland is overtaken by Canada, which was ranked number 17 with $420,159,373.17 Million PPP and is followed by Slovenia at $343,555,237.12 Million PPP. United States topped the ranking with $70,565,318,932.39 Million PPP in 2019, an increase of 3.3% versus 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland witnessed the best average annual growth at +43.9% per year, while Lithuania was the worst growing country at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2019 | 407,799,563.58 |
| 2018 | 392,868,201.95 |
| 2017 | 431,982,757.45 |
| 2016 | 280,588,270.79 |
| 2015 | 179,129,729.17 |
How does Ireland rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
| 17 |
#17
Canada
|
420,159,373.17 | 2019 | -1.6 % | +2.3 % | View data | |
| 18 |
#18
Ireland
|
407,799,563.58 | 2019 | +3.8 % | +16.9 % | View data | |
| 19 |
#19
Slovenia
|
343,555,237.12 | 2019 | +3.1 % | +4.5 % | View data | |